Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume $0.04 +0.00 (+12.50%) As of 02/21/2025 01:23 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Emmaus Life Sciences Short Interest DataEmmaus Life Sciences (EMMA) has a short interest of 21,700 shares. This marks a 47.62% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 40,297 shares to cover all short positions.Current Short Interest21,700 sharesPrevious Short Interest14,700 sharesChange Vs. Previous Month+47.62%Dollar Volume Sold Short$353.71Short Interest Ratio1.1 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares63,870,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume100 sharesAverage Trading Volume40,297 sharesToday's Volume Vs. Average0% Short Selling Emmaus Life Sciences? Sign up to receive the latest short interest report for Emmaus Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEMMA Short Interest Over TimeEMMA Days to Cover Over TimeEMMA Percentage of Float Shorted Over Time Emmaus Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202521,700 shares $353.71 +47.6%N/A1.1 $0.02 1/15/202514,700 shares $205.80 +2,000.0%N/A0.6 $0.01 12/31/2024700 shares $5.95 No ChangeN/A0 $0.01 12/15/2024700 shares $4.69 -22.2%N/A0 $0.01 11/30/2024900 shares $26.91 -10.0%N/A0 $0.03 11/15/20241,000 shares $36.50 +42.9%N/A0 $0.04 10/31/2024700 shares $24.50 No ChangeN/A0 $0.04 10/15/2024700 shares $24.50 No ChangeN/A0 $0.04 9/30/2024700 shares $20.86 No ChangeN/A0 $0.03 9/15/2024700 shares $26.25 No ChangeN/A0 $0.04 Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024700 shares $0.21 No ChangeN/A1 $0.00 8/15/2024700 shares $2.10 No ChangeN/A0 $0.00 7/31/2024700 shares $1.75 No ChangeN/A0.1 $0.00 7/15/2024700 shares $49.91 No ChangeN/A0 $0.07 6/30/2024700 shares $70.70 No ChangeN/A0 $0.10 6/15/2024700 shares $64.01 No ChangeN/A0.1 $0.09 5/31/2024700 shares $64.40 No ChangeN/A0.1 $0.09 5/15/2024700 shares $72.10 No ChangeN/A0.3 $0.10 4/30/2024700 shares $70.00 No ChangeN/A0.1 $0.10 4/15/2024700 shares $73.50 -12.5%N/A0.9 $0.11 3/31/2024800 shares $84.00 -89.5%N/A0.1 $0.11 3/15/20247,600 shares $768.36 +33.3%N/A0.4 $0.10 2/29/20245,700 shares $676.02 +714.3%N/A0.1 $0.12 2/15/2024700 shares $67.27 -93.6%N/A0.1 $0.10 1/15/20244,100 shares $369.00 -6.8%N/A0.4 $0.09 12/31/20234,400 shares $440.33 +450.0%N/A0 $0.10 12/15/2023800 shares $88.00 -50.0%N/A0.1 $0.11 11/30/20231,600 shares $208.00 +128.6%N/A0 $0.13 11/15/2023700 shares $77.00 No ChangeN/A0 $0.11 10/31/2023700 shares $84.00 No ChangeN/A0 $0.12 10/15/2023700 shares $105.00 -22.2%N/A0 $0.15 9/30/2023900 shares $112.50 No ChangeN/A0.5 $0.13 9/15/2023900 shares $117.00 +28.6%N/A0.1 $0.13 8/31/2023700 shares $105.88 -41.7%N/A0 $0.15 8/15/20231,200 shares $252.00 No ChangeN/A0.4 $0.21 7/31/20231,200 shares $264.00 +71.4%N/A0.2 $0.22 7/15/2023700 shares $168.35 -50.0%N/A0.1 $0.24 6/30/20231,400 shares $322.00 -68.9%N/A0.2 $0.23 6/15/20234,500 shares $1,215.00 -65.1%N/A0.8 $0.27 5/31/202312,900 shares $4,128.00 +1,742.9%N/A0.5 $0.329/9 on TSLA from June to January (Ad)Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!Tap here to catch the TGT case study and learn more 5/15/2023700 shares $224.00 -83.7%N/A0 $0.32 4/30/20234,300 shares $1,354.50 -4.4%N/A0.2 $0.32 4/15/20234,500 shares $1,485.00 +50.0%N/A0.1 $0.33 3/31/20233,000 shares $907.50 +328.6%N/A0.3 $0.30 3/15/2023700 shares $245.00 No ChangeN/A0.1 $0.35 2/28/2023700 shares $266.00 -91.9%N/A0.1 $0.38 2/15/20238,600 shares $4,042.00 +244.0%N/A0.2 $0.47 1/31/20232,500 shares $999.50 +257.1%N/A0 $0.40 1/15/2023700 shares $203.00 No ChangeN/A0 $0.29 12/30/2022700 shares $182.21 -87.7%N/A0 $0.26 12/15/20225,700 shares $1,881.00 +714.3%N/A0.2 $0.33 11/30/2022700 shares $271.60 -86.0%N/A0 $0.39 11/15/20225,000 shares $1,500.00 +72.4%N/A0.2 $0.30 10/31/20222,900 shares $1,305.00 +314.3%N/A0 $0.45 10/15/2022700 shares $126.00 No ChangeN/A0 $0.18 9/30/2022700 shares $119.00 -53.3%N/A0 $0.17 9/15/20221,500 shares $450.00 No ChangeN/A0.2 $0.30 8/31/20221,500 shares $540.00 +87.5%N/A0.1 $0.36 8/15/2022800 shares $296.00 +14.3%N/A0 $0.37 7/31/2022700 shares $245.00 No ChangeN/A0 $0.35 7/15/2022700 shares $280.00 No ChangeN/A0.1 $0.40 6/30/2022700 shares $315.00 No ChangeN/A0.1 $0.45 6/15/2022700 shares $252.00 -66.7%N/A0 $0.36 5/31/20222,100 shares $840.00 -83.5%N/A0 $0.40 5/15/202212,700 shares $3,190.24 +693.8%N/A0.2 $0.25 4/30/20221,600 shares $1,280.00 -5.9%N/A0.2 $0.80 4/15/20221,700 shares $1,292.77 +142.9%N/A0 $0.76 3/31/2022700 shares $700.00 -12.5%N/A0 $1.00 3/15/2022800 shares $1,088.00 No ChangeN/A0.1 $1.36 2/28/2022800 shares $1,160.00 -33.3%N/A0 $1.45 2/15/20221,200 shares $1,740.00 +71.4%N/A0 $1.45 1/31/2022700 shares $980.00 -12.5%N/A0 $1.40 1/15/2022800 shares $1,148.00 +14.3%N/A0 $1.44 12/31/2021700 shares $1,169.00 No ChangeN/A0 $1.67 12/15/2021700 shares $1,071.00 -50.0%N/A0 $1.53 11/30/20211,400 shares $3,010.00 -57.6%N/A0 $2.15 11/15/20213,300 shares $4,026.00 +230.0%N/A0.1 $1.22 10/29/20211,000 shares $1,430.00 -23.1%N/A0.1 $1.43 10/15/20211,300 shares $2,106.00 No ChangeN/A0.1 $1.62 9/30/20211,300 shares $2,080.00 +44.4%N/A0.1 $1.60 9/15/2021900 shares $1,296.00 -79.6%N/A0 $1.44 8/31/20214,400 shares $6,820.00 +46.7%N/A0.3 $1.55 8/13/20213,000 shares $4,650.00 -37.5%N/A0.3 $1.55 7/30/20214,800 shares $7,200.00 +433.3%N/A0.4 $1.50 7/15/2021900 shares $1,350.00 No ChangeN/A0.1 $1.50 6/30/2021900 shares $1,278.00 -70.0%N/A0.1 $1.42 6/15/20213,000 shares $4,800.00 +150.0%N/A0.3 $1.60 5/28/20211,200 shares $1,944.00 +33.3%N/A0.2 $1.62 5/14/2021900 shares $1,305.00 -74.3%N/A0 $1.45 4/30/20213,500 shares $4,515.00 +288.9%N/A0.1 $1.299/9 on TSLA from June to January (Ad)Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!Tap here to catch the TGT case study and learn more 4/15/2021900 shares $1,215.00 +28.6%N/A0.1 $1.35 3/31/2021700 shares $1,197.00 No ChangeN/A0 $1.71 3/15/2021700 shares $1,050.00 -50.0%N/A0 $1.50 2/26/20211,400 shares $1,974.00 -33.3%N/A0 $1.41 2/12/20212,100 shares $3,507.00 -12.5%N/A0 $1.67 1/29/20212,400 shares $2,928.00 -11.1%N/A0.8 $1.22 1/15/2021700 shares $861.00 -68.2%N/A0 $1.23 12/31/2020700 shares $805.00 No ChangeN/A0 $1.15 12/15/2020700 shares $770.00 -68.2%N/A0 $1.10 11/30/20202,200 shares $2,640.00 -31.3%N/A0.1 $1.20 11/15/20203,200 shares $2,720.00 +3.2%N/A0.1 $0.85 10/30/20203,100 shares $2,542.00 -75.2%N/A0.2 $0.82 10/15/202012,500 shares $9,400.00 +468.2%N/A0.3 $0.75 9/30/20202,200 shares $2,134.00 +144.4%N/A0.1 $0.97 9/15/2020900 shares $1,044.00 -40.0%N/A0 $1.16 EMMA Short Interest - Frequently Asked Questions What is Emmaus Life Sciences' current short interest? Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 21,700 shares of EMMA short. Learn More on Emmaus Life Sciences' current short interest. What is a good short interest ratio for Emmaus Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EMMA shares currently have a short interest ratio of 1.0. Learn More on Emmaus Life Sciences's short interest ratio. Is Emmaus Life Sciences' short interest increasing or decreasing? Emmaus Life Sciences saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 21,700 shares, an increase of 47.6% from the previous total of 14,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Emmaus Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Emmaus Life Sciences: PharmaCyte Biotech, Inc. (0.50%), Inhibitor Therapeutics, Inc. (0.00%), BetterLife Pharma Inc. (0.02%), Talphera, Inc. (0.54%), Lotus Pharmaceuticals, Inc. (0.00%), Kiora Pharmaceuticals, Inc. (0.68%), Jaguar Health, Inc. (7.86%), Brainstorm Cell Therapeutics Inc. (2.06%), Ainos, Inc. (9.10%), Relmada Therapeutics, Inc. (2.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Emmaus Life Sciences stock? Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. EMMA shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emmaus Life Sciences? A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further. How often is Emmaus Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies PharmaCyte Biotech Short Squeeze Inhibitor Therapeutics Short Squeeze BetterLife Pharma Short Squeeze Talphera Short Squeeze Lotus Pharmaceuticals Short Squeeze Kiora Pharmaceuticals Short Squeeze Jaguar Health Short Squeeze Brainstorm Cell Therapeutics Short Squeeze Ainos Short Squeeze Relmada Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EMMA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMMA Stock Alerts